Jean El-Cheikh

Jean El-Cheikh

I received my MD from the Medical School Federico II at the University of Naples in Italy in 1999, followed by advanced training in Bone Marrow Transplantation for both autologous and allogeneic transplants, as part of the Hematology training at the Post Graduate School of Hematology and the Institute Seragnoli of Hematology and Medical Oncology,…

I received my MD from the Medical School Federico II at the University of Naples in Italy in 1999, followed by advanced training in Bone Marrow Transplantation for both autologous and allogeneic transplants, as part of the Hematology training at the Post Graduate School of Hematology and the Institute Seragnoli of Hematology and Medical Oncology, University of Bologna, Italy. In 2003, I moved to France and until 2015 I was a Junior Faculty “Chef de Clinique Assistant” (Onco-Hematology Service II) at the Institut J. Paoli – I. Calmettes, Marseilles. Then, I moved to Lebanon in 2015 and joined the Bone Marrow Transplantation program at the American University of Beirut Medical Center as an Assistant Professor till present. I have a significant experience in the field of multiple myeloma and transplantation, with a special clinical focus on developing reduced-toxicity conditioning regimens and immunomodulation. I have clinical and research experience in infectious diseases and supportive care in the context of intensive therapy for hematologic malignancies. It is in that perspective that I have written so far around 120 papers focused primarily on Bone Marrow Transplantation (BMT), Hematologic Malignancies, the supportive care and antifungal prophylaxis in heavily immunosuppressive patients. During the past 3 years, I have initiated, conducted and published more than 45 studies in these areas, with a major focus on the management of the intensity of the conditioning regimen, the personalized conditioning for transplant, the feasibility of transplant in very elderly patients, the use of alternative donors from mismatched donors and the introduction of the haplo-identical transplantation from related donors in Lebanon,  the acute and chronic Graft versus Host Disease (GvHD), immunomodulation post-transplant, the use of the monoclonal antibodies for prevention and/or treatment of the relapse, and finally the infectious complications (viral, fungal and bacterial) in our transplanted patients at AUBMC.

I am a member of many scientific societies such as the European Group of Blood and Marrow Transplantation (EBMT), the European Hematology Association, and many French and European societies. Also, I serve as a reviewer for major journals such as Blood, Transplantation, Bone Marrow Transplantation, Leukemia & lymphoma, European Journal of Hematology, and Blood Cancer Journal, and editorial board member in Bone Marrow Transplantation, Journal of Clinical Research and Medicine, American Journal of Epidemiology & Public Health, and Clinical Microbiology and Infectious Diseases.